Manufacturing in the Industry 4.0 era...

Logo
Presented by

Christos Varsakelis at GlaxoSmithKline Biologicals SA & Mark Demesmaeker, at Sartorius & Roger-Marc Nicoud at Ypso-Facto

About this talk

Full Title: Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted The manufacturing status quo reflects a compromise between innovation and performance. But the battle between these values is perpetual and, in the dawn of Industry 4.0 era, a new compromise between technological progress and the need for stationarity is being crafted. Being able to successfully harvest the benefits of the fourth industrial revolution requires a) separating facts from fiction and b) getting acquainted with the never-before-encountered bottlenecks that will have to be deal with. In this talk, we will go through the unique opportunities and the unprecedented challenges accompanying the fourth industrial revolution. The point of view, however, is not that of the salesman, which is frequently encountered online, but rather of the buyer, i.e. manufacturing.  The objective, therefore, is simple, albeit arduous: transform the buyer of this negotiation table into an informed investor that no-longer faces a competitive disadvantage.

Related topics:

More from this channel

Upcoming talks (28)
On-demand talks (300)
Subscribers (29501)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.